Refold Therapeutics joins forces with UCB to tackle light chain amyloidosis, a rare disease damaging the heart and kidneys.

Preprocedural vascular sheath insertion improved survival in high-risk PCI without increasing complications. Learn more about ...

ADT with leuprolide was tied to increased coronary plaque vs relugolix in prostate cancer. What does this mean for CV risk?

Interviews in Pakistan highlight what people with HIV want from long-acting injectable antiretroviral therapy and what may ...

Cognitive impairment affects most haemodialysis patients and is linked to reduced physical function. What are the clinical implications? Read more.

Find out more about how metabolic and bariatric surgery offers greater cardiovascular protection than GLP-1 receptor agonists.

As Ukraine enters its fifth year of full-scale war, 80% of Ukrainians are unable to access the medicines they need. Read more.

Find out more about how AI has matched the diagnostic accuracy of expert endoscopists in detecting early gastric cancer.

Ublituximab shows five year relapse reduction and disability benefits in multiple sclerosis, supporting early high efficacy treatment strategies today.

Cluster RCT finds mobile instant messaging exercise reminders did not significantly boost lab-verified smoking cessation at 6 months.

Macro B12 identified in 24% of patients with raised vitamin B12, suggesting polyethylene glycol testing may reduce unnecessary bone marrow biopsy.

The deal is a unified effort to advance a CAR T-cell therapy currently under regulatory review for multiple myeloma.